Oncology/Anti-cancer drugs Market to Expand at a Healthy CAGR of 8.6% through 2025
Oncology/Anti-cancer drugs Market to Expand at a Healthy CAGR of 8.6% through 2025
Source: sandiegosun.com
📰 Roche Diagnostics News
Page 72 - Roche Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Roche Diagnostics. Real-time updates on events, politics, business and more.
Oncology/Anti-cancer drugs Market to Expand at a Healthy CAGR of 8.6% through 2025
Oncology/Anti-cancer drugs Market to Expand at a Healthy CAGR of 8.6% through 2025
Source: texasguardian.com
Senate HELP advances Califf nomination in close vote
The vote puts the Biden administration one step closer to installing a permanent leader atop the agency.
Source: politico.com
Millions of Tricare Beneficiaries Left Out of COVID-19 Test Reimbursement Plan
The military health program will not reimburse for home test kits, but Tricare beneficiaries still will be able to pick up free kits at distribution centers as available.
Source: military.com
Hemostasis Analyzers Market Size Worth $6,490.24 Million, Globally, by 2028 at 9.5% CAGR - Exclusive Report by The Insight Partners
The Hemostasis Analyzers Market Size is driven by high prevalence of cardiovascular diseases and the rise in the geriatric population. The laboratory analyzer segment held a larger market share
Source: finanznachrichten.de
Hemostasis Analyzers Market Size Worth $6,490.24 Million, Globally, by 2028 at 9.5% CAGR - Exclusive Report by The Insight Partners
/PRNewswire/ -- According to the new market research report "Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type...
Source: prnewswire.com
Roche launches the cobas® pulse system, an industry first professional blood glucose management solution with mobile digital health capabilities to improve patient care
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the launch of the cobas® pulse system in select countries accepting the CE Mark. The cobas® pulse system marks Roche Diagnostics’ newest generation of connected point of care solutions for professional blood glucose management. As an industry first, the cobas® ...
United States Diab Endocrinol Thomas Schinecker Steadysense Steadytemp Laboratory Standards Institute Roche Group
Source: pharmiweb.com
Hemostasis Analyzers Market Size Worth $6,490.24 Million, Globally, by 2028 at 9.5% CAGR - Exclusive Report by The Insight Partners
/PRNewswire/ -- According to the new market research report "Hemostasis Analyzers Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type...
Source: prnewswire.com
Codagenix Welcomes Bruce Taillon as Executive Vice President of Animal Health
/PRNewswire/ -- Codagenix, Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic virus therapies, today...
Brucee Taillon J Robert Coleman Carnegie Mellon University Animal Health At Codagenix Business Product Development Enzo Life Sciences
Source: prnewswire.com